
via News-Medical.Net
Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers. The study was posted in March on Gastroenterology, the online journal of the American Gastroenterological Association. Print publication is scheduled for July.
While therapies have been available to treat some forms of liver disease, including hepatitis C and autoimmune hepatitis, options have been more limited for treating portal hypertension, a condition where there is an increase in pressure within the portal vein that carries blood from abdominal organs to the liver. Portal hypertension is associated with cirrhosis and other chronic liver diseases.
According to the study, the drug sivelestat may effectively lower portal hypertension, improving symptoms and outcomes for those patients. The study results were obtained from mouse models but have since been confirmed in liver samples from humans, according to Vijay Shah, M.D., a Mayo Clinic gastroenterologist and senior author.
“This was an exciting confirmation of our findings and their applicability to human disease,” Dr. Shah says. “Sivelestat has been safely used in humans with acute lung injury and bronchopulmonary dysplasia. This suggests that sivelestat and similar drugs constitute a potential means to decrease portal hypertension in patients with chronic liver disease.”
The Mayo study showed that deposits of fibrin — microvascular blood clots — contributed to portal hypertension, and inflammatory cells known as neutrophils contributed to the formation of fibrin. By inhibiting neutrophil function with sivelestat, they were able to decrease portal hypertension.
“Neutrophils had not previously been identified as significant drivers of portal hypertension,” says Moira Hilscher, M.D., the paper’s first author. Results were verified in two different models of chronic liver disease.
“The study paves the way for developing new drugs and repurposing of existing compounds to target inflammation in the liver driven by disease-related mechanical forces,” says Dr. Hilscher. “Given the increasing prevalence of advanced liver disease due to alcohol and obesity, this is clearly an unmet need.”
Learn more: Mayo Clinic researchers identify potential new therapy for liver diseases
The Latest on: Liver diseases
[google_news title=”” keyword=”liver diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Liver diseases
- Non-alcoholic fatty liver disease: Hepatokines mediate its impact on metabolic diseases and help to identify subtypeson February 7, 2023 at 1:29 pm
Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases. In a Perspective in Cell Metabolism, Norbert Stefan from the University of ...
- Antibody candidate for treating serious liver diseaseon February 7, 2023 at 4:37 am
A new study led by researchers from Karolinska Institutet in Sweden has identified an antibody candidate for the treatment of fatty liver.
- Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detectionon February 7, 2023 at 2:53 am
The study identifies a set of volatile organic compounds (VOCs) that can identify patients with liver disease and separate them based on severity. Non-alcoholic fatty liver disease (NAFLD) and ...
- Owlstone Medical announces key study results on use of Breath Biopsy for improved detection of liver disease including NASH and NAFLDon February 6, 2023 at 10:15 pm
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates ...
- Sobering facts about wine, women and liver diseaseon February 6, 2023 at 10:25 am
If you missed the chance to join the popular "Dry January" challenge, it's not too late to take a break from wine, beer or liquor. If you completed the challenge, congratulations and keep going.
- Study reveals antibody therapy for treating liver diseaseon February 6, 2023 at 9:49 am
There is presently no medication available to treat non-alcoholic fatty liver disease which affects many patients with type 2 diabetes and can lead to other se ...
- Potential Drug Candidate Identified for Fatty Liver Diseaseon February 6, 2023 at 2:03 am
Select - Yes No There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases. A study ...
- Coffee May Protect You From Liver Disease, New Study Findson February 4, 2023 at 5:00 am
Research shows that drinking coffee may be able to help protect you from liver disease, which means you're free to pour that second cup.
- Liver Disease Claims Lives at an Alarming Rate, Say Experts—Know the Signson February 4, 2023 at 4:01 am
For years there's been a disturbing trend of young adults experiencing severe and often fatal liver disease and the problem continues.
- On Nutrition: Dealing with fatty liver diseaseon January 24, 2023 at 8:45 pm
Here is a list of gifts from organizations will quite literally sustain the receiver long after the holiday is over.
via Bing News